| Message | Subject | Recs | Date/Time (ET) |
|
QUESTION: Anyone know if compassionate care extends to dogs? Friend of mine ha | Provectus Pharmaceuticals Inc. | | 10/01/2012 04:43:54 PM |
| HemOnc Conference--- did I miss something? We have not received any feedback on | Provectus Pharmaceuticals Inc. | | 04/16/2012 08:53:38 AM |
| The results have an outstanding probability p=.001. Doubtful you have had better | Provectus Pharmaceuticals Inc. | | 03/19/2012 08:40:17 AM |
| Dees Presentation:
1. Sounded upbeat about FDA status - "great Christmas presen | Provectus Pharmaceuticals Inc. | 6 | 01/18/2012 02:07:49 PM |
| I don't understand the "one shot" point. It appears from the appendix that sever | Provectus Pharmaceuticals Inc. | 1 | 01/18/2012 09:35:58 AM |
| Master:
The good: No more NTTG rebuttles to waste your time
The bad: knowled | Provectus Pharmaceuticals Inc. | | 01/06/2012 02:19:01 PM |
| Master- thanks for your valued contribution. You have been a voice of influence | Provectus Pharmaceuticals Inc. | | 01/06/2012 01:22:12 PM |
| Boomer: The number of FDA meetings usually is several... not just a couple. So d | Provectus Pharmaceuticals Inc. | | 01/06/2012 01:17:30 PM |
| Spin Offs:
Today PVCT made an announcement regarding the spin offs.
I woul | Provectus Pharmaceuticals Inc. | | 12/20/2011 12:58:46 PM |
| To PVCT Board Members:
I just signed on to look at the day's notes. Of the to | Provectus Pharmaceuticals Inc. | 4 | 12/15/2011 08:32:26 PM |
| Master I think it is correct to think that if there was MOA support for the drug | Provectus Pharmaceuticals Inc. | | 12/13/2011 01:52:10 PM |
| CMON ... like this NTTG would know or even give you a serious response.
We k | Provectus Pharmaceuticals Inc. | 1 | 12/13/2011 01:38:10 PM |
| First of all a correction to my previous statement: I had lag factor on: For 201 | Provectus Pharmaceuticals Inc. | | 12/08/2011 04:37:59 PM |
| The model calculates a revenue for a year based on a market share and CAGR of tr | Provectus Pharmaceuticals Inc. | | 12/08/2011 03:07:09 PM |
| Simply ask Dees or Peter C. !
| Provectus Pharmaceuticals Inc. | | 12/08/2011 02:34:33 PM |
| Master,
Anyway you cut it, $500M for PH Derm is woefully low unless you really | Provectus Pharmaceuticals Inc. | | 12/08/2011 12:23:47 PM |
| Yes master. The modeling of likely profits from derm licensure indicate that $50 | Provectus Pharmaceuticals Inc. | | 12/07/2011 02:18:25 PM |
| The report by eHEALTH that there are no side affects is encouraging and jives wi | Provectus Pharmaceuticals Inc. | 5 | 11/17/2011 11:30:16 AM |
| Yes, completely agree. Saw not only opportunity, but got a team that could execu | Provectus Pharmaceuticals Inc. | | 10/05/2011 08:29:40 PM |
| Master--- good point. While using PV10 with other drug would show incremental be | Provectus Pharmaceuticals Inc. | | 09/08/2011 11:59:38 AM |
| Master- RE: [i]Tired Board[/i]
Yes, you are right, but to some extent folks a | Provectus Pharmaceuticals Inc. | | 09/07/2011 01:02:15 PM |
| Master- Unclear about the specific purpose of the R&R conference, especially sin | Provectus Pharmaceuticals Inc. | | 09/06/2011 03:40:01 PM |
| Master,
NTTG is a trained master at invoking fear and twisting facts. He feed | Provectus Pharmaceuticals Inc. | 2 | 09/01/2011 12:30:29 PM |
| It is both sad and truly amazing!
This board is about the mutual exchange of | Provectus Pharmaceuticals Inc. | | 07/20/2011 04:25:21 PM |
| Who knows NTTG. Both names refer to liver cancer. So unless you know, why imply | Provectus Pharmaceuticals Inc. | 6 | 07/06/2011 02:06:13 PM |
| To NTTG:
A review of the treated change shows the following:
From:Recurren | Provectus Pharmaceuticals Inc. | | 07/06/2011 12:08:30 PM |
| LIVER Trial- clinicalTrials.gov status:
http://clinicaltrials.gov/ct2/show/NCT0 | Provectus Pharmaceuticals Inc. | | 07/06/2011 09:26:51 AM |
| Old info NTTG- the percentage of stage 3 & 4 increased also thereby dampening re | Provectus Pharmaceuticals Inc. | | 06/29/2011 04:34:47 PM |
| A wise man leaves with dignity. A wiser man learns and teaches others. | Provectus Pharmaceuticals Inc. | | 06/21/2011 09:23:47 PM |
| Thanks master. Good article. | Provectus Pharmaceuticals Inc. | | 06/02/2011 01:53:09 PM |
| Interesting note Master. Could you possibly refer me to the CNBC article on pani | Provectus Pharmaceuticals Inc. | | 06/01/2011 03:13:41 PM |
| Good article M! | Provectus Pharmaceuticals Inc. | | 05/27/2011 12:37:37 PM |
| Master: Regarding the value of AD and PS and the stock only at a buck:
1)You co | Provectus Pharmaceuticals Inc. | | 05/16/2011 08:38:28 AM |
| LT
Regarding the 2.3m remaining warrants expiring May 19th, any idea of the ex | Provectus Pharmaceuticals Inc. | | 05/14/2011 10:38:27 AM |
| Master: A bit of confusion likely caused by my terminology.
The Discounted Ca | Provectus Pharmaceuticals Inc. | | 05/13/2011 06:46:50 PM |
| Yes Master... the share is likely low. And the indicated market size for AD and | Provectus Pharmaceuticals Inc. | | 05/13/2011 01:46:47 PM |
| The team is quite busy and a bit behind in updating the trials.gov site. The cha | Provectus Pharmaceuticals Inc. | | 05/12/2011 01:34:08 PM |
| PONDERING THE ORPHAN DRUG DESIGNATION:
It is kind of natural for a board to f | Provectus Pharmaceuticals Inc. | | 04/27/2011 01:07:33 PM |
| $420 MM is peanuts when you calculate the target population and dose revenue. PS | Provectus Pharmaceuticals Inc. | | 04/08/2011 10:48:41 AM |
| Master - Yes that would be explosive ... lots of fun too! A bunch of us, includi | Provectus Pharmaceuticals Inc. | | 04/03/2011 02:18:24 PM |
| Regarding Orphan Drug Status for PV 10, PVCT received this c. 2007.
So I gues | Provectus Pharmaceuticals Inc. | | 04/02/2011 05:37:24 PM |
| I agree tax day is a good bet. Below is link to current trials.gov rept. I bet e | Provectus Pharmaceuticals Inc. | | 04/02/2011 01:18:09 PM |
| Excellent Post PI!
I contemplate whether this process also allows them to cre | Provectus Pharmaceuticals Inc. | | 03/25/2011 06:37:14 AM |
| FUNNY!
Yes the shareholders should show up in lab coats and rah rah signs fo | Provectus Pharmaceuticals Inc. | | 03/08/2011 11:15:54 AM |
| Yes Shoes, there is interest
Help me though... what is the evidence that the | Provectus Pharmaceuticals Inc. | | 03/06/2011 04:49:52 PM |
| [http://www.news-medical.net/news/20110209/Humira-and-Enbrel-have-best-overall-c | Provectus Pharmaceuticals Inc. | | 02/09/2011 07:46:50 PM |
| Lets be objective:
1. Shareholders do not understand this move based on state | Provectus Pharmaceuticals Inc. | | 01/13/2011 10:38:53 AM |
| TO BRADPALM1:
The recent approved patent (January) talks not only about addit | Provectus Pharmaceuticals Inc. | | 01/11/2011 03:14:33 PM |
| TO BRADPALM1:
The recent approved patent (January) talks not only about addit | Provectus Pharmaceuticals Inc. | | 01/10/2011 06:03:02 PM |
| -PI I agree. However what is not absolutely clear to me what ranges PLR's respon | Provectus Pharmaceuticals Inc. | 1 | 12/17/2010 09:44:30 PM |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.